Dr. S. Eswara Reddy was appointed the Drugs Controller General (India) in February 2018. He is the youngest Drugs Controller General (I) who has worked for all the positions of the hierarchies. At CDSCO, Dr. Reddy headed various internal divisions like medical devices, biologicals, new drugs, import & registration and others.
Dr. Reddy started his career in 1998 as a Drugs Inspector at CDSCO, West Zone, Mumbai. At CDSCO, Mumbai he has conducted GMP, GCP and GLP audits. He promoted as Assistant Drugs Controller of India in 2009 and appointed as Deputy Drugs Controller (India) in 2012. In 2014, he was appointed as Joint Drugs Controller (India).
Dr. Reddy is recipient of Best Drugs Inspector Award in 2005, Best Drugs Control Officer in 2016 and Distinguished Alumni Award from Manipal Academy of Higher Education, Manipal.
With the vision to promote public health, he was actively involved in framing of Medical Devices Rules 2017, 12th Five Year Plan for strengthening of Indian Drugs Regulatory System and international matters related to MOUs, SOI, and other quality issues. He has organized numerous trainings for CDSCO officials to enhance their knowledge and make them competent. He has conducted Risk Based Inspections to ensure the quality of drugs being marketed India.
Dr. Reddy did his PhD from J.N.T.U, Hyderabad. He has vast experience in manufacturing of pharmaceuticals, academic research and drug regulations. He has published articles in various journals.
He works with a great enthusiasm and is committed to safeguard and enhance the public health by assuring the safety, efficacy and quality of drugs, cosmetics and medical devices.